The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Vasenina E.E.

Rossiĭskaia meditsinskaia akademiia poslediplomnogo obrazovaniia, Moskva

Gan'kina O.A.

Rossiĭskaia meditsinskaia akademiia poslediplomnogo obrazovaniia, Moskva

Neuropsychiatric disorders in dementia: mechanisms and treatment approach

Authors:

Vasenina E.E., Gan'kina O.A.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(6‑2): 58‑65

DOI: 10.17116/jnevro20171176258-65

Read: 6275 times

Download PDF (RU)
Contact the author
Table of contents

NEUROPSYCHIATRIC DISORDERS IN DEMENTIA: MECHANISMS AND TREATMENT APPROACH
NEUROPSYCHIATRIC DISORDERS IN DEMENTIA: MECHANISMS AND TREATMENT APPROACH

To cite this article:

Vasenina EE, Gan'kina OA. Neuropsychiatric disorders in dementia: mechanisms and treatment approach. S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(6‑2):58‑65. (In Russ.)
https://doi.org/10.17116/jnevro20171176258-65

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски (S.S. Korsakov Journal of Neurology and Psychiatry (special issues))
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Stress and sleep: Neurobiological aspe­cts and modern options of inso­mnia therapy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5-2):14-21
The main mechanisms of deve­lopment of cognitive impairment. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):13-18
Prospects for treating Alzheimer’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):54-60
Cognitive impairment in patients with multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):67-73
Postoperative peri­tonitis: epidemiology, diagnosis, surgical treatment and prognosis. Piro­gov Russian Journal of Surgery. 2025;(6):104-111
Early diagnosis and effe­ctive therapy of diabetic poly­neuropathy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):62-68
Treatment features of patients with vascular cognitive impairments. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):69-76
Portopulmonary hype­rtension. Journal of Respiratory Medi­cine. 2025;(2):39-44
Diagnosis and treatment of ovarian cancer in pregnancy. Russian Bulletin of Obstetrician-Gynecologist. 2025;(3):27-33
Rapi­dly progressive periodontitis. (A successful expe­rience of eighteen years of obse­rvation). Russian Journal of Stomatology. 2025;(2):61-67
Abstract:

Behavioral and psychological symptoms of dementia can manifest at various stages during the disease. Prominence and rate of progression may depend on nosological form of dementia as well as environmental factors, concomitant diseases et al. Each psychiatric symptom is based on the specific neurotransmitter imbalance and differentiated involvement of various parts of the Central Nervous System in the pathological process. Treatment in each case should be chosen individually taking into account the balance of benefits and risks of prescribed drugs.

Keywords:

psychiatric disorders
dementia
treatment

Authors:

Vasenina E.E.

Rossiĭskaia meditsinskaia akademiia poslediplomnogo obrazovaniia, Moskva

Gan'kina O.A.

Rossiĭskaia meditsinskaia akademiia poslediplomnogo obrazovaniia, Moskva

Close metadata

References:

  1. Vasenina EE, Levin OS. Characteristics of the clinical picture and treatment of moderate or severe Alzheimer’s disease. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2015;115(6. Vyp. 2):17-25. (In Russ.). https://doi.org/10.17116/jnevro20151156217-25
  2. Levin OS, Vasenina EE. Twenty-five years of the amyloid hypothesis of alzheimer disease: advances, failures and new perspectives. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2016;116(6. Vyp. 2):3-12. (In Russ.). https://doi.org/10.17116/jnevro2016116623-9
  3. Gutorova DA, Vasenina EE, Levin OS. Screening of cognitive impairment in the old and old-old population with the 3-CT scale. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2016;116(6. Vyp. 2):35-42. (In Russ.). https://doi.org/10.17116/jnevro20161166235-40
  4. Preuss U, Wong J, Koller G. Treatment of behavioral and psychological symptoms of dementia: a systematic review. Psychiatria Polska. 2016;50(4): 679-715. https://doi.org/10.12740/pp/64477
  5. Aalten P, de Vugt M, Jaspers N, Jolles J, Verhey F. The course of neuropsychiatric symptoms in dementia. Part II: relationships among behavioural sub-syndromes and the influence of clinical variables. International Journal of Geriatric Psychiatry. 2005;20(6):531-536. https://doi.org/10.1002/gps.1317
  6. Fox C, Crugel M, Maidment I, Auestad B, Coulton S, Treloar A, Ballard C, Boustani M, Katona C, Livingston G. Efficacy of Memantine for Agitation in Alzheimer’s Dementia: A Randomised Double-Blind Placebo Controlled Trial. PLoS ONE. 2012;7(5):35185. https://doi.org/10.1371/journal.pone.0035185
  7. Li X, Hu N, Tan M, Yu J, Tan L. Behavioral and Psychological Symptoms in Alzheimer’s Disease. BioMed Research International. 2014;1-9. https://doi.org/10.1155/2014/927804
  8. Zahodne L, Ornstein K, Cosentino S, Devanand D, Stern Y. Longitudinal Relationships Between Alzheimer Disease Progression and Psychosis, Depressed Mood, and Agitation/Aggression. The American Journal of Geriatric Psychiatry. 2015;23(2):130-140. https://doi.org/10.1016/j.jagp.2013.03.014
  9. Robert P, Berrut G, Bonin-Guillaume S, Mekies C, Bakchine S, Benoit M, Doussaint J, Schuck S, Marquet T. Estime study: Apathy and depression in mild and newly diagnosed Alzheimer disease. Alzheimer’s & Dementia. 2011;7(4):362-363. https://doi.org/10.1016/j.jalz.2011.05.1045
  10. Kwak Y, Yang Y, Pyo S, Koo M. Clinical characteristics according to depression screening tools in patients with Alzheimer’s disease: View from self, caregiver-reported and drug-intervention pattern. Geriatrics & Gerontology International. 2013;14(3):660-666. https://doi.org/10.1111/ggi.12154
  11. Lenoir H, Dufouil C, Auriacombe S, Lacombe J, Dartigues J, Ritchie K, Tzourio C. Depression history, depressive symptoms and incident dementia: The 3C study. Alzheimer’s & Dementia. 2011;7(4):355-356. https://doi.org/10.1016/j.jalz.2011.05.1029
  12. Holmes C, Arranz M, Collier D, Powell J, Lovestone S. Depression in Alzheimer’s disease: The effect of serotonin receptor gene variation. American Journal of Medical Genetics. 2003;119B(1):40-43. https://doi.org/10.1002/ajmg.b.10068
  13. Pritchard A, Pritchard C, Bentham P, Lendon C. Role of Serotonin Transporter Polymorphisms in the Behavioural and Psychological Symptoms in Probable Alzheimer Disease Patients. Dementia and Geriatric Cognitive Disorders. 2007;24(3):201-206. https://doi.org/10.1159/000107081
  14. Blasko I, Kemmler G, Jungwirth S, Wichart I, Krampla W, Weissgram S, Jellinger K, Tragl K, Fischer P. Plasma Amyloid Beta-42 Independently Predicts Both Late-Onset Depression and Alzheimer Disease. The American Journal of Geriatric Psychiatry. 2010;18(11):973-982. https://doi.org/10.1097/jgp.0b013e3181df48be
  15. Kang J, Lee J, Kang H, Lee H, Kim Y, Jeon H, Chung J, Lee M, Cho M, Lee D. Regional Cerebral Blood Flow Abnormalities Associated With Apathy and Depression in Alzheimer’s Disease. Alzheimer Disease & Associated Disorders. 2012;26(3):217-224. https://doi.org/10.1097/wad.0b013e318231e5fc
  16. Lebedev A, Beyer M, Fritze F, Westman E, Ballard C, Aarsland D. Cortical Changes Associated with Depression and Antidepressant Use in Alzheimer and Lewy Body Dementia: An MRI Surface-based Morphometric Study. The American Journal of Geriatric Psychiatry. 2014;22(1):4-13. https://doi.org/10.1016/j.jagp.2013.02.004
  17. Brommelhoff J, Spann B, Go J, Mack W, Gatz M. Striatal Hypodensities, Not White Matter Hypodensities on CT, Are Associated with Late-Onset Depression in Alzheimer’s Disease. Journal of Aging Research. 2011;1-11. https://doi.org/10.4061/2011/187219
  18. Bidzan L, Bidzan M, Pąchalska M. Aggressive and impulsive behavior in Alzheimer’s disease and progression of dementia. Medical Science Monitor. 2012;18(3):182-189. https://doi.org/10.12659/msm.882523
  19. Lanctôt K. Central Serotonergic Activity is Related to the Aggressive Behaviors of Alzheimer’s Disease. Neuropsychopharmacology. 2012. https://doi.org/10.1016/s0893-133x(02)00339-1
  20. Sweet R, Nimgaonkar V, Kamboh M, Lopez O, Zhang F, DeKosky S. Dopamine Receptor Genetic Variation, Psychosis, and Aggression in Alzheimer’s Disease. Archives of Neurology. 1998;55(10):1335. https://doi.org/10.1001/archneur.55.10.1335
  21. Matthews K, Chen C, Esiri M, Keene J, Minger S, Francis P. Noradrenergic changes, aggressive behavior, and cognition in patients with dementia. Biological Psychiatry. 2002;51(5):407-416. https://doi.org/10.1016/s0006-3223(01)01235-5
  22. Guadagna S, Esiri M, Williams R, Francis P. Tau phosphorylation in human brain: relationship to behavioral disturbance in dementia. Neurobiology of Aging. 2012;33(12):2798-2806. https://doi.org/10.1016/j.neurobiolaging.2012.01.015
  23. Trzepacz P, Yu P, Bhamidipati P, Willis B, Forrester T, Tabas L, Schwarz A, Saykin A. Frontolimbic atrophy is associated with agitation and aggression in mild cognitive impairment and Alzheimer’s disease. Alzheimer’s & Dementia. 2013;9(5):95-104. https://doi.org/10.1016/j.jalz.2012.10.005
  24. Esposito F, Rochat L, Van der Linden A, Lekeu F, Quittre A, Charnallet A, Van der Linden M. Apathy and Executive Dysfunction in Alzheimer’s Disease. Alzheimer Disease & Associated Disorders. 2010;24(2):131-137. https://doi.org/10.1097/wad.0b013e3181c9c168
  25. Mori T, Shimada H, Shinotoh H, Hirano S, Eguchi Y, Yamada M, Fukuhara R, Tanimukai S, Zhang M, Kuwabara S, Ueno S, Suhara T. Apathy correlates with prefrontal amyloid deposition in Alzheimer’s disease. Journal of Neurology, Neurosurgery & Psychiatry. 2013;85(4):449-455. https://doi.org/10.1136/jnnp-2013-306110
  26. Donovan N, Wadsworth L, Lorius N, Locascio J, Rentz D, Johnson K, Sperling R. Regional cortical thinning predicts worsening apathy and hallucinations in mild cognitive impairment and mild Alzheimer’s disease dementia. Alzheimer’s & Dementia. 2012;8(4):342-343. https://doi.org/10.1016/j.jalz.2012.05.943
  27. Lee C, Hahn C, Won W. Apathy and white matter in Alzheimer’s disease: A whole-brain analysis with tract-based spatial statistics. Alzheimer’s & Dementia. 2013;9(4):373-374. https://doi.org/10.1016/j.jalz.2013.05.728
  28. Gilley D, Bienias J, Wilson R, Bennett D, Beck T, Evans D. Influence of behavioral symptoms on rates of institutionalization for persons with Alzheimer’s disease. Psychological Medicine. 34(6):1129-1135. https://doi.org/10.1017/s0033291703001831
  29. Creese B, Ballard C, Jones E. Cognitive Impairment in Studies of 5HTTLPR and Psychosis in Alzheimer’s Disease: A Systematic Review. Dementia and Geriatric Cognitive Disorders. 2013;35(3-4):155-164. https://doi.org/10.1159/000346733
  30. Ertekin-Taner N. Alzheimer’s disease: The quest for Alzheimer disease genes — focus on CSF tau. Nature Reviews Neurology. 2013;9(7):368-370. https://doi.org/10.1038/nrneurol.2013.117
  31. Koppel J, Sunday S, Goldberg T, Davies P, Christen E, Greenwald B. Psychosis in Alzheimer’s Disease is Associated with Frontal Metabolic Impairment and Accelerated Decline in Working Memory: Findings from the Alzheimer’s Disease Neuroimaging Initiative. The American Journal of Geriatric Psychiatry. 2014;22(7):698-707. https://doi.org/10.1016/j.jagp.2012.10.028
  32. Rafii M, Taylor C, Kim H, Desikan R, Fleisher A, Katibian D, Brewer J, Dale A, Aisen P. Neuropsychiatric Symptoms and Regional Neocortical Atrophy in Mild Cognitive Impairment and Alzheimer’s Disease. American Journal of Alzheimer’s Disease & Other Dementias. 2014;29(2):159-165. https://doi.org/10.1177/1533317513507373
  33. Nomura K, Kazui H, Wada T, Sugiyama H, Yamamoto D, Yoshiyama K, Shimosegawa E, Hatazawa J, Takeda M. Classification of delusions in Alzheimer’s disease and their neural correlates. Psychogeriatrics. 2012; 12(3):200-210. https://doi.org/10.1111/j.1479-8301.2012.00427.x
  34. Kales H, Gitlin L, Lyketsos C. Assessment and management of behavioral and psychological symptoms of dementia. BMJ. 2015;350(mar02 7):369-369. https://doi.org/10.1136/bmj.h369
  35. Hodgson N, Gitlin L, Winter L, Czekanski K. Undiagnosed Illness and Neuropsychiatric Behaviors in Community Residing Older Adults With Dementia. Alzheimer Disease & Associated Disorders. 2011;25(2):109-115. https://doi.org/10.1097/wad.0b013e3181f8520a
  36. Husebo B, Ballard C, Cohen-Mansfield J, Seifert R, Aarsland D. The Response of Agitated Behavior to Pain Management in Persons with Dementia. The American Journal of Geriatric Psychiatry. 2014;22(7):708-717. https://doi.org/10.1016/j.jagp.2012.12.006
  37. Clare L, Wilson B, Carter G, Breen K, Berrios G, Hodges J. Depression and anxiety in memory clinic attenders and their carers: implications for evaluating the effectiveness of cognitive rehabilitation interventions. International Journal of Geriatric Psychiatry. 2002;17(10):962-967. https://doi.org/10.1002/gps.735
  38. Cooper C, Balamurali T, Selwood A, Livingston G. A systematic review of intervention studies about anxiety in caregivers of people with dementia. International Journal of Geriatric Psychiatry. 2007;22(3):181-188. https://doi.org/10.1002/gps.1656
  39. Lyketsos C, DelCampo L, Steinberg M, Miles Q, Steele C, Munro C, Baker A, Sheppard J, Frangakis C, Brandt J, Rabins P. Treating Depression in Alzheimer Disease. Archives of General Psychiatry. 2003;60(7):737. https://doi.org/10.1001/archpsyc.60.7.737
  40. Rabins P. Backed-up against the wall: Pharmacology to assuage the PAADS (psychosis, apathy, agitation, depression, sleep problems) clusters in dementia. Alzheimer’s & Dementia. 2013;9(4):2. https://doi.org/10.1016/j.jalz.2013.04.510
  41. Drye L, Spragg D, Devanand D, Frangakis C, Marano C, Meinert C, Mintzer J, Munro C, Pelton G, Pollock B, Porsteinsson A, Rabins P, Rosenberg P, Schneider L, Shade D, Weintraub D, Yesavage J, Lyketsos C. Changes in QTc Interval in the Citalopram for Agitation in Alzheimer’s Disease (CitAD) Randomized Trial. PLoS ONE. 2014;9(6):98426. https://doi.org/10.1371/journal.pone.0098426
  42. Apreda M, Cano F, Foces-Foces C, Lopez-Ruperez F, Conesa J, Soria J. ChemInform Abstract: Crystal and Molecular Structure of the Alimemazine Cation Radical. ChemInform. 1997;18(35). https://doi.org/10.1002/chin.198735057
  43. Alimemazine Increases Night-time Sleep. InPharma. 1987;586(1):8-8. https://doi.org/10.1007/bf03305903
  44. Alimemazine Surpasses Diazepam as Paediatric Premedication. InPharma. 1987;592(1):8-8. https://doi.org/10.1007/bf03291381
  45. Georgeson K. ffectiveness of alimemazine in controlling retching after Nissen fundoplication. Yearbook of Surgery. 2007;235-236. https://doi.org/10.1016/s0090-3671(08)70180-0
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.